Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control

Front Immunol. 2024 Oct 22:15:1478063. doi: 10.3389/fimmu.2024.1478063. eCollection 2024.

Abstract

Introduction: Spontaneous control of chronic-phase HIV/SIV viremia is often associated with the expression of specific MHC class I allotypes. HIV/SIV-specific CD8+ cytotoxic T lymphocytes (CTLs) restricted by these MHC class I allotypes appear to be critical for viremic control. Establishment of the elite controller (EC) phenotype is predictable in SIVmac239-infected Indian rhesus macaques (RMs), with approximately 50% of Mamu-B*08+ RMs and 20% of Mamu-B*17+ RMs becoming ECs. Despite extensive characterization of EC-associated CTLs in HIV/SIV-infected individuals, the precise mechanistic basis of elite control remains unknown. Because EC and non-EC viral load trajectories begin diverging by day 14 post-infection, we hypothesized that hyperacute innate immune responses may contribute to viremic control.

Methods: To gain insight into the immunological factors involved in the determination of EC status, we vaccinated 16 Mamu-B*08+ RMs with Vif and Nef to elicit EC-associated CTLs, then subjected these 16 vaccinees and an additional 16 unvaccinated Mamu-B*08+ controls to repeated intrarectal SIVmac239 challenges. We then performed whole-blood transcriptomic analysis of all 32 SIVmac239-infected Mamu-B*08+ RMs and eight SIVmac239-infected Mamu-B*08 - RMs during the first 14 days of infection.

Results: Vaccination did not provide protection against acquisition, but peak and setpoint viremia were significantly lower in vaccinees relative to controls. We did not identify any meaningful correlations between vaccine-induced CTL parameters and SIVmac239 acquisition rate or chronic-phase viral loads. Ultimately, 13 of 16 vaccinees (81%) and 7 of 16 controls (44%) became ECs (viremia ≤ 10,000 vRNA copies/mL plasma for ≥ 4 weeks). We identified subsets of immunomodulatory genes differentially expressed (DE) between RM groupings based on vaccination status, EC status, and MHC class I genotype. These DE genes function in multiple innate immune processes, including the complement system, cytokine/chemokine signaling, pattern recognition receptors, and interferon-mediated responses.

Discussion: A striking difference in the kinetics of differential gene expression among our RM groups suggests that Mamu-B*08-associated elite control is characterized by a robust, rapid innate immune response that quickly resolves. These findings indicate that, despite the association between MHC class I genotype and elite control, innate immune factors in hyperacute SIV infection preceding CTL response development may facilitate the establishment of the EC phenotype.

Keywords: acquired immunodeficiency syndrome (AIDS); cytotoxic T lymphocytes (CTLs); human immunodeficiency virus (HIV); simian immunodeficiency virus (SIV); vaccines.

MeSH terms

  • Animals
  • Histocompatibility Antigens Class I / immunology
  • Immunity, Innate*
  • Macaca mulatta*
  • Simian Acquired Immunodeficiency Syndrome* / immunology
  • Simian Acquired Immunodeficiency Syndrome* / virology
  • Simian Immunodeficiency Virus* / immunology
  • T-Lymphocytes, Cytotoxic / immunology
  • Viral Load*
  • Viremia* / immunology

Substances

  • Histocompatibility Antigens Class I

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by R01 AI052056 (PI: DW) and F30 AI147881 (PI: BR) from the National Institute of Allergy and Infectious Diseases (NIAID) and supported in part with federal funds from the National Cancer Institute under contract 75N91019D00024/HHSN261201500003. Infrastructure for this study was also supported by NIAID contract HHSN272201300010C, NIAID grant P01 AI177688 (PI: MJ), and grant P51 OD010425 to the Washington National Primate Research Center. The funders of this study had no role in its design, data collection and analysis, decision to publish, or manuscript preparation.